News

Oxford researchers have developed programmable microcapsules to deliver vaccines in stages, potentially eliminating the need ...
In previous treat-to-target trials, adjustments to the dose of basal insulin have been made at least weekly, according to ...
Objective: To compare the antipyretic and analgesic effects of a single oral dose of diclofenac potassium 6.25, 12.5 or 25mg with paracetamol 1000mg and placebo in patients with fever resulting ...
Single-dose baloxavir reduces household influenza transmission. ScienceDaily . Retrieved June 11, 2025 from www.sciencedaily.com / releases / 2025 / 04 / 250425113801.htm ...
Eli Lilly and Company has announced the availability of Zepbound (tirzepatide) in 2.5mg and 5mg single-dose vials for self-pay for adults with obesity. The move significantly expands the supply of ...
A single dose of VERVE-102 led to a 53% mean and 69% max LDL-C reduction at 0.6 mg/kg. No treatment-related SAEs or lab abnormalities were observed in 14 participants across three dose levels ...
Deadly cholesterol that doesn’t show up on routine tests is slashed by 94% with single dose of new drug By ... of Cardiology in Chicago and published in the The New England Journal of Medicine.
Single-dose gene therapy is potentially life-changing for adults with hemophilia B. ScienceDaily. Retrieved June 2, 2025 from www.sciencedaily.com / releases / 2024 / 09 / 240925172115.htm ...
The trial met its primary endpoint, showing a single, oral dose of Xofluza taken by people infected with influenza reduced the odds of untreated household members contracting the virus by 32%.
Telehealth company Ro said on Wednesday it will offer single-dose vials of Eli Lilly's weight-loss drug Zepbound to patients with obesity, becoming the first alternative platform for the lower ...
Zepbound injection is approved as a 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, or 15 mg per 0.5 mL in single-dose pen or single-dose vial. Learn more Zepbound is a prescription medicine.
Starter doses of the weight-loss drug Zepbound are now available in single-dose vials, drug manufacturer Eli Lilly announced Tuesday, a move the company says will “significantly” expand supply ...